Condition: Overweight · Obesity · Sponsor: Eli Lilly and Company
The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants with overweight or obesity and type 2 diabetes. Participation in the study will last about 75 weeks.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Birmingham Clinical Research | Birmingham, Alabama, United States | Recruiting |
| Cullman Clinical Trials | Cullman, Alabama, United States | Recruiting |
| Tucson Clinical Research Institute | Tucson, Arizona, United States | Recruiting |
| San Fernando Valley Health Institute | Canoga Park, California, United States | Recruiting |
| AMCR Institute | Escondido, California, United States | Recruiting |
| NorCal Medical Research, Inc | Greenbrae, California, United States | Recruiting |
| Ark Clinical Research | Long Beach, California, United States | Recruiting |
| Pacific Clinical Studies | Los Alamitos, California, United States | Recruiting |
| Inglewood Clinical | Los Angeles, California, United States | Recruiting |
| Care Access - Santa Clarita | Santa Clarita, California, United States | Recruiting |
| Encompass Clinical Research | Spring Valley, California, United States | Recruiting |
| Diablo Clinical Research, Inc. | Walnut Creek, California, United States | Recruiting |
+ 147 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07282600